Literatur
Kurian AW, McClure LA, John EM et al (2009) Second primary breast cancer occurence according to hormone receptor status. J Natl Cancer Inst 101:1058–1065
Malone KE, Begg CB, Haile RW et al (2010) Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2. J Clin Oncol 28:2404–2410
Nichols H, Berrington de Gonzalez A, Lacey JV Jr et al (2011) Declining incidence of contralateral breast cancer in the United States from 1975 to 2006. J Clin Oncol 29:1564–1569
Tilanus-Linthorst MM, Alves C, Seynaeve C et al (2006) Contralateral recurrence and prognostic factors in familial non-BRCA1/2-associated breast cancer. Br J Surg 93:961–968
Tilanus-Linthorst MM, Bartels KC, Alves C et al (2006) Selection bias influences reported contralateral breast cancer incidence and survival in high risk non-BRCA1/2 patients. Breast Cancer Res Treat 95:117–123
Einhaltung der ethischen Richtlinien
Interessenkonflikt
E.-M. Grischke gibt an, dass kein Interessenkonflikt besteht. Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Grischke, EM. Prophylaktische kontralaterale Mastektomie. Onkologe 19, 671–672 (2013). https://doi.org/10.1007/s00761-013-2514-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00761-013-2514-0